CERVIX | CERVICAL SCREENING [ISSN 1804-087X]
česky | english | sitemap


PARTNERS AND EXPERT GUARANTEE
 
Czech Gynaecological and Obstetrical Society | Ministry of Health | Institute of Biostatistics and Analyses, Masaryk University
GRANT SUPPORT OF THE PROJECT
 
GlaxoSmithKline     Roche |

Other sources of information
Cervical cytology (in Czech)www.cipek.cz
Cervical cytology
 
Cancer Screening in the European Unionec.europa.eu
Cancer Screening in the European Union (2017)
[ 10,6 MB]
 
SVOD - Epidemiology of malignant tumours in the Czech Republicwww.svod.cz
Epidemiology of malignant tumours
in the Czech Republic
 
NCI Bethesda System
HPV College

 

News for health professionals

Epidemiology of cervical cancer Screening process References

Archive

Year: 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008


Cancer screening programmes and their informational support: situation in the Czech Republic in 2014
18.12.2014 IBA MU | More information...

A special issue of Klinicka onkologie (the official journal of the Czech Society for Oncology), published in December 2014, is dedicated to the assessment of cancer prevention efforts and results in the Czech Republic. A team of authors not only described the current situation in cancer prevention programmes in the Czech Republic, but also pointed out weak spots in cancer prevention efforts.

Nine-valent HPV vaccine may prevent nearly 90 percent of cervical cancers
1.10.2014 AACR Press Release | More information...

Because nine human papillomavirus (HPV) subtypes were found to cause the majority of cervical precancers, a nine-valent HPV vaccine currently being investigated may be able to prevent more cervical cancers than current vaccines, according to research published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.


Back